Pathway Financial Advisors’s GMO International Value ETF GMOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Sell
47,468
-2,365
-5% -$89K 0.21% 48
2026
Q1
$1.82M Buy
49,833
+445
+0.9% +$16K 0.23% 46
2025
Q4
$1.69M Buy
49,388
+5,021
+11% +$161K 0.21% 46
2025
Q3
$1.38M Buy
44,367
+5,999
+16% +$183K 0.18% 52
2025
Q2
$1.12M Buy
38,368
+28,054
+272% +$772K 0.16% 55
2025
Q1
$275K Buy
+10,314
New +$265K 0.05% 137

Other funds holding GMOI

Pathway Financial Advisors's GMOI Position: Q2 2026 in Review

Pathway Financial Advisors reduced its GMO International Value ETF (GMOI) stake by 4.7% in Q2 2026, selling an estimated $89K and leaving 47,468 shares worth $1.81M. The position accounts for 0.21% of the portfolio, ranked #48.

Pathway Financial Advisors first reported a position in GMOI in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.82M in Q1 2026. 20 funds tracked by Wall St. Rank hold GMOI as of Q2 2026.

  • Pathway Financial Advisors held 47,468 shares of GMO International Value ETF worth $1.81M as of Q2 2026.
  • Pathway Financial Advisors sold 2,365 GMO International Value ETF shares in Q2 2026, an estimated $89K.
  • GMO International Value ETF made up 0.21% of Pathway Financial Advisors's portfolio in Q2 2026, its #48 holding.
  • Pathway Financial Advisors first reported a position in GMO International Value ETF in Q1 2025 and has held it in 6 quarters since.
  • Pathway Financial Advisors's GMO International Value ETF position peaked at $1.82M in Q1 2026.
  • 20 funds tracked by Wall St. Rank held GMO International Value ETF as of Q2 2026.

Based on Pathway Financial Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.